Many fibrotic diseases and malignant tumors are associated with platelet-derived growth factor receptor beta (PDGFRβ) overexpression and disproportionate signaling, making this receptor attractive for molecular targeting and imaging approaches. The gene discussed is PDGFRB; the disease is cancer.